Cancer clinical trials are a critical part of bringing new therapies to life. These studies are made possible by patients who agree to participate, allowing researchers to measure the effects of potentially new and better treatments that may extend a patient’s life and/or improve their quality of life. An overwhelming number of clinical trials fail […]
En savoir plus
Researchers in Canada are seeking feedback on your experience with declining or participating in a clinical trial via an on-line, anonymous survey. To access this on-line survey, please click here. Photo courtesy of BCCRIN Lire l’article en français >
En savoir plus
On March 22nd, all Q-CROC liaison coordinators attended the 52nd RALi (Rencontre des agents de liaison) teleconference meeting, along with several members of the Q-CROC team. Topics covered included the Fair Market Value Working Group that met earlier this month in Toronto (see related article), the initiative at the CHU Quebec City to centralize budget review […]
En savoir plus
CCTCC Fair Market Value (FMV) Working Group (WG) On March 6th, representatives from several healthcare institutions and pharmaceutical companies met in Toronto to take part in the Fair Market Value (FMV) initiative working group (WG), led by the Canadian Clinical Trials Coordinating Centre (CCTCC). Among the participants, Maisonneuve-Rosemont Hospital and the Center […]
En savoir plus
The board of directors of the CHUM Research Centre (CRCHUM) has announced the appointment of Dr. Normand Blais as Assistant Scientific Director of Clinical Research for cancer research development. His mandate will focus on improving quality of care and facilitating the development and integration of innovations for the benefit of patients. Q-CROC congratulates […]
En savoir plus
Q-CROC welcomes the announcement of the creation of the Oncopole, born from a public-private partnership between the Fonds de recherche du Québec – Santé (FRQS) and Merck Canada Inc. The Oncopole is an inspiring, innovative and structuring project for the province of Québec. Not unlike Q-CROC, the Oncopole’s vision is to bring about a […]
En savoir plus
From left to right: Thérèse Gagnon-Kugler (Q-CROC), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Stéphanie Ibrahim (CIUSSS du Nord-de-l’Île-de-Montréal), Tasnim Daginawala (CIUSSS du Centre-Ouest-de-l’Île-de-Montréal), Philippe Cornellier (Q-CROC), Claire Gagnon (CISSS du Bas-Saint-Laurent), Martin Gaudreau (Q-CROC), Mélanie LeBlanc (Q-CROC), Marie-Pierre Desrosiers (CISSS de l’Outaouais), Anne Brochu (CIUSSS de l’Estrie – […]
En savoir plus
Q-CROC is pleased to welcome the CHU Sainte-Justine as the 11th member-institution of its clinical research network in oncology. CHU Sainte-Justine has positioned itself Canada’s largest mother-child hospital center and one of the ten largest pediatric centers in the world. CHU Sainte-Justine hosts a cancer center, in charge of the pediatric bone marrow and […]
En savoir plus
The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the a comprehensive genetic analysis of prostate cancer tumors in the journal Nature. This project was financed by Prostate Cancer Canada with the help of donations received through the Movember campaign. Watch the video published by Prostate Cancer Canada via its YouTube channel. […]
En savoir plus
From left to right: Solange Tremblay (CISSS de Laval), Anne Brochu (CIUSSS de l’Estrie – CHUS), Claire Gagnon (CISSS du Bas-Saint-Laurent), Marie Saint-Jacques (CHU Sainte-Justine), Cynthia Lévesque (CIUSSS de l’Est-de-l’Île-de-Montréal), Martin Gaudreau (Q‑CROC), Tasnim Daginawala (CIUSSS du Centre-Ouest-de-l’Île-de-Montréal), Hugo Garneau (CHU de Québec – Université Laval), Anrrieth Paredes (CHUM). Absents de la photo, mais présents […]
En savoir plus